You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Investigational Drug Information for Dapansutrile


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Dapansutrile?

Dapansutrile is an investigational drug.

There have been 7 clinical trials for Dapansutrile. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2022.

The most common disease conditions in clinical trials are Syndrome, COVID-19, and Gout. The leading clinical trial sponsors are Olatec Therapeutics LLC, Merck Sharp & Dohme Corp., and April Salama, M.D.

Recent Clinical Trials for Dapansutrile
TitleSponsorPhase
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-DiaEuropean Union (Horizon Europe Programme)Phase 2
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-DiaOlatec Therapeutics LLCPhase 2
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-DiaState Secretariat for Education Research and Innovation, SwitzerlandPhase 2

See all Dapansutrile clinical trials

Clinical Trial Summary for Dapansutrile

Top disease conditions for Dapansutrile
Top clinical trial sponsors for Dapansutrile

See all Dapansutrile clinical trials

International Patents for Dapansutrile

Drugname Country Document Number Estimated Expiration Related US Patent
Dapansutrile Australia AU2011344030 2030-12-15 ⤷  Sign Up
Dapansutrile Brazil BR112013014583 2030-12-15 ⤷  Sign Up
Dapansutrile Canada CA2820625 2030-12-15 ⤷  Sign Up
Dapansutrile China CN103260613 2030-12-15 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.